C4 therapeutics appoints lauren white as chief financial officer

Watertown, mass., may 20, 2021 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced the appointment of lauren white to the role of chief financial officer, effective june 21, 2021. ms. white's appointment will initiate william (bill) mckee's planned transition from interim chief financial officer, a role he has held since march 31, 2020. mr. mckee will remain engaged to support c4t in a part-time consulting capacity to ensure a smooth transition.
CCCC Ratings Summary
CCCC Quant Ranking